tiprankstipranks
Trending News
More News >
Beijing Tong Ren Tang Chinese Medicine Co (HK:3613)
:3613
Hong Kong Market
Advertisement

Beijing Tong Ren Tang Chinese Medicine Co (3613) Ratios

Compare
1 Followers

Beijing Tong Ren Tang Chinese Medicine Co Ratios

HK:3613's free cash flow for Q2 2025 was HK$0.61. For the 2025 fiscal year, HK:3613's free cash flow was decreased by HK$ and operating cash flow was HK$0.35. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
18.17 11.65 8.80 15.38 13.54
Quick Ratio
11.43 8.59 7.68 13.35 11.25
Cash Ratio
8.28 3.03 4.76 7.79 6.58
Solvency Ratio
1.71 1.51 1.48 2.29 2.16
Operating Cash Flow Ratio
2.63 1.40 1.31 3.65 0.54
Short-Term Operating Cash Flow Coverage
7.99K 2.78K 2.50K 1.62K 446.36
Net Current Asset Value
HK$ 3.61BHK$ 3.43BHK$ 3.20BHK$ 2.98BHK$ 2.65B
Leverage Ratios
Debt-to-Assets Ratio
0.03 0.03 0.02 0.03 0.03
Debt-to-Equity Ratio
0.04 0.03 0.03 0.04 0.04
Debt-to-Capital Ratio
0.03 0.03 0.03 0.04 0.03
Long-Term Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Financial Leverage Ratio
1.13 1.15 1.17 1.12 1.13
Debt Service Coverage Ratio
7.01K 111.06 158.39 139.96 142.79
Interest Coverage Ratio
0.00 104.41 174.12 165.38 155.68
Debt to Market Cap
<0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
0.17 0.16 0.13 0.16 0.13
Net Debt to EBITDA
-2.75 -1.11 -2.08 -1.80 -1.72
Profitability Margins
Gross Profit Margin
63.00%68.67%66.44%71.95%72.45%
EBIT Margin
33.97%45.49%47.98%50.32%52.47%
EBITDA Margin
35.04%51.12%52.43%54.80%58.47%
Operating Profit Margin
34.14%40.93%46.88%50.02%50.89%
Pretax Profit Margin
37.21%45.10%47.71%50.02%52.15%
Net Profit Margin
30.16%35.44%37.31%39.06%41.24%
Continuous Operations Profit Margin
31.29%38.73%40.02%41.85%43.24%
Net Income Per EBT
81.06%78.57%78.20%78.09%79.09%
EBT Per EBIT
108.98%110.20%101.77%99.99%102.46%
Return on Assets (ROA)
11.37%12.19%15.29%15.85%15.88%
Return on Equity (ROE)
12.72%13.98%17.92%17.78%17.98%
Return on Capital Employed (ROCE)
13.51%15.21%21.32%21.49%20.92%
Return on Invested Capital (ROIC)
11.21%12.88%17.65%17.73%17.10%
Return on Tangible Assets
11.53%12.34%15.51%16.11%16.13%
Earnings Yield
7.02%5.25%6.73%5.41%7.95%
Efficiency Ratios
Receivables Turnover
4.04 3.61 1.88 2.95 2.41
Payables Turnover
12.54 2.70 3.78 12.62 4.89
Inventory Turnover
0.43 0.47 1.24 1.01 0.73
Fixed Asset Turnover
3.95 3.49 4.27 3.78 3.35
Asset Turnover
0.38 0.34 0.41 0.41 0.38
Working Capital Turnover Ratio
0.46 0.45 0.55 0.54 0.52
Cash Conversion Cycle
902.59 739.00 393.25 455.88 575.86
Days of Sales Outstanding
90.41 101.24 194.66 123.71 151.64
Days of Inventory Outstanding
841.28 772.98 295.15 361.10 498.87
Days of Payables Outstanding
29.10 135.22 96.57 28.93 74.65
Operating Cycle
931.70 874.22 489.82 484.81 650.51
Cash Flow Ratios
Operating Cash Flow Per Share
0.68 0.55 0.65 0.93 0.14
Free Cash Flow Per Share
0.62 0.52 0.61 0.90 0.12
CapEx Per Share
0.06 0.03 0.05 0.03 0.02
Free Cash Flow to Operating Cash Flow
0.91 0.95 0.93 0.97 0.89
Dividend Paid and CapEx Coverage Ratio
1.66 1.55 1.14 3.46 0.56
Capital Expenditure Coverage Ratio
11.73 21.08 14.22 33.17 9.01
Operating Cash Flow Coverage Ratio
3.97 3.50 5.31 6.05 1.09
Operating Cash Flow to Sales Ratio
0.33 0.30 0.32 0.50 0.09
Free Cash Flow Yield
7.07%4.26%5.31%6.71%1.51%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
14.25 19.05 14.85 18.48 12.58
Price-to-Sales (P/S) Ratio
4.30 6.75 5.54 7.22 5.19
Price-to-Book (P/B) Ratio
1.82 2.66 2.66 3.29 2.26
Price-to-Free Cash Flow (P/FCF) Ratio
14.15 23.46 18.85 14.90 66.12
Price-to-Operating Cash Flow Ratio
12.95 22.34 17.52 14.45 58.79
Price-to-Earnings Growth (PEG) Ratio
8.69 -1.22 2.71 1.50 -8.30
Price-to-Fair Value
1.82 2.66 2.66 3.29 2.26
Enterprise Value Multiple
9.51 12.09 8.49 11.38 7.15
Enterprise Value
5.70B 9.43B 7.71B 9.70B 5.50B
EV to EBITDA
9.51 12.09 8.49 11.38 7.15
EV to Sales
3.33 6.18 4.45 6.23 4.18
EV to Free Cash Flow
10.98 21.48 15.14 12.87 53.33
EV to Operating Cash Flow
10.04 20.46 14.08 12.48 47.41
Tangible Book Value Per Share
4.97 4.74 4.40 4.16 3.67
Shareholders’ Equity Per Share
4.81 4.62 4.31 4.08 3.60
Tax and Other Ratios
Effective Tax Rate
0.16 0.14 0.16 0.16 0.17
Revenue Per Share
2.04 1.82 2.07 1.86 1.57
Net Income Per Share
0.62 0.65 0.77 0.73 0.65
Tax Burden
0.81 0.79 0.78 0.78 0.79
Interest Burden
1.10 0.99 0.99 0.99 0.99
Research & Development to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
0.12 0.12 0.09 0.10 0.11
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
1.10 0.85 0.66 1.00 0.17
Currency in HKD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis